GroovyStocks has the scoop on Pfizer's new drug.
New Blockbuster Drug Approved for Pfizer (PFE)
Pfizer Inc (PFE) announced today that the FDA has approved a new drug, Trythinking, which will help hedge fund managers and other investors cope with a host of maladies.
One of the most common diseases among hedge fund managers is Monthitis which prevents those afflicted with it from thinking about consequences and events that stand to occur after the end of upcoming calendar month, which is when results are typically report to partners. In clinical trials, patients on Trythinking had a median holding period for their investments of 2 days vs. 42 minutes for those on the placebo.
We've heard Trythinking works even better than crushed adderall. And it doesn't leave blue stains on your nose.
New Blockbuster Drug Approved for Pfizer (PFE) [Groovy Stocks]